FLT4 and lymphangioma: To test the therapeutic effect of COX-2 selective inhibition on LM progression, we administered celecoxib to Pik3caH1047R;Vegfr3-CreERT2 mice 10 d after induction of lymphatic vessel overgrowth (Fig. 9 G).